GenesisCare and Elekta in USD 100 Million Strategic Partnership

Elekta (Stockholm, Sweden), a company pioneering cancer and brain disorders treatment solutions, has announced a multiyear strategic partnership with GenesisCare (Alexandria, NSW, Australia), the largest radiotherapy provider in Australia.

The eight-year partnership is valued at more than USD 100 million and includes Elekta's Leksell Gamma Knife radiosurgery system, brachytherapy systems, Versa HD linear accelerators, software, and services for use in GenesisCare cancer treatment centers in Australia, the UK, and in new markets.

The agreement also includes Elekta’s MOSAIQ enterprise licensing system, and the METRIQ software. The MOSAIQ software enables a completely optimized and automated workflow across a global enterprise, while the METRIQ software is an integrated cancer registry, including reporting, and follow-up analysis.

Dan Collins, managing director of GenesisCare, said, "Elekta is a natural partner for GenesisCare. We want all cancer patients to receive rapid access to high quality care. Elekta helps us make this happen with their suite of technology solutions, global reach and commitment to innovation. The MR-linac is a game changer. We expect cancer patients, including those receiving treatment for prostate, breast and other cancers, to benefit from this innovation. Anything that improves the accuracy of treatment and provides a smoother patient experience should improve outcomes."

Related Links:
Elekta
GenesisCare